An Observational Study of Patients With Chronic Gastrointestinal Disease

Running, not enrolling

Conditions studied: Gastrointestinal Diseases

In brief

TARGET-GASTRO is an observational research study to conduct a comprehensive review of outcomes for patients with the chronic gastrointestinal (GI) diseases: eosinophilic gastrointestinal disease (EGID), ulcerative colitis (UC) or Crohn's disease (CD).

Key facts

Study ID

NCT05774080

Run by

Target PharmaSolutions, Inc.

People needed

500000

Starts

2023-08-01

Expected to finish

2037-12-01

Last updated by the study team

2026-01-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult* patients at the time of enrollment with a diagnosis or major symptom of EGIDs, UC, or CD by ICD-10 code in the EHR interface

You may not qualify if…

• Death
• Manual removal (sponsor or site request)
• No EHR interface encounter > 3 years.
• Engaged Cohort
• Inclusion Criteria:
• Adult* patients diagnosed and managed for these conditions invited to participate
• Ability to provide written informed consent
• Exclusion Criteria:
• Patient expressed desire to withdraw consent to complete PROs
• Failure to complete PROs within 24 weeks of initial invitation
• Greater than 24 months lapse of survey completion after baseline surveys completed
• Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort.

Where it is running

• Atrium Health/Wake Forest University School of Medicine — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.